Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Am J Med. 2011 Nov;124(11):1081.e9-22. doi: 10.1016/j.amjmed.2011.05.028.
Patient nonadherence to prescribed medication is common and limits the effectiveness of treatment for many conditions. Most adherence studies evaluate behavior only among patients who have filled a first prescription. The advent of electronic prescribing (e-prescribing) systems provides the opportunity to track initial prescriptions and identify nonadherence that may have previously been undetected.
We analyzed e-prescribing data and filled claims for all patients with CVS Caremark (Woonsocket, RI) drug coverage who received e-prescriptions from the iScribe e-prescribing system in calendar 2008. We matched e-prescriptions with filled claims by using data on the drug name, date of e-prescription, and date of filled claims, allowing up to 180 days for patients to fill e-prescriptions. We evaluated the rate of primary nonadherence to newly prescribed medications across multiple characteristics of patients, prescribers, and prescriptions and developed multivariable models to identify predictors of nonadherence.
We identified 423,616 e-prescriptions for new medications, with 3634 prescribers and 280,081 patients. The primary nonadherence rate was 24.0%. Several factors were associated with nonadherence to e-prescriptions, including nonformulary status of medications (odds ratio [OR] 1.31 compared with preferred medications; 95% confidence interval [CI], 1.26-1.36; P<.001) and residence in a low-income ZIP code (OR 1.23 compared with high-income ZIP code; 95% CI, 1.17-1.30; P<.001) Nonadherence occurred less often when e-prescriptions were transmitted directly to the pharmacy rather than printed to give to patients (OR 0.54; 95% CI, 0.52-0.57; P<.001).
24% of e-prescriptions for new medications were not filled. Our results suggest that interventions to address economic barriers and increase electronic integration in the healthcare system may be promising approaches to improve medication adherence.
患者不遵医嘱服药的现象很常见,这限制了许多疾病的治疗效果。大多数依从性研究仅评估已开具首剂处方的患者的行为。电子处方(e-prescribing)系统的出现提供了跟踪初始处方和识别以前未被发现的不依从性的机会。
我们分析了 CVS Caremark(罗得岛州沃斯堡)药物覆盖范围内所有使用 iScribe 电子处方系统接受电子处方的患者的电子处方和已填药物报销申请数据。我们通过药物名称、电子处方日期和已填药物报销申请日期的数据来匹配电子处方和已填药物报销申请,允许患者在 180 天内填写电子处方。我们评估了新处方药物在患者、处方医生和处方多个特征下的首次不依从率,并开发了多变量模型来确定不依从的预测因素。
我们确定了 423616 张新处方药物的电子处方,涉及 3634 名处方医生和 280081 名患者。首次不依从率为 24.0%。一些因素与电子处方不依从有关,包括药物非处方状态(与首选药物相比,比值比 [OR] 1.31;95%置信区间 [CI],1.26-1.36;P<.001)和居住在低收入邮政编码区(与高收入邮政编码区相比,OR 1.23;95%CI,1.17-1.30;P<.001)。当电子处方直接发送到药房而不是打印给患者时,不依从的情况较少(OR 0.54;95%CI,0.52-0.57;P<.001)。
24%的新处方药物未被患者填写。我们的结果表明,解决经济障碍和增加医疗保健系统电子整合的干预措施可能是提高药物依从性的有前途的方法。